Subcutaneous Infliximab Found Effective With or Without an Immunosuppressant

Patients who achieved a clinical response to subcutaneous infliximab showed no meaningful differences in outcomes ...

MARCH 5, 2025

Solving the Nutrition–Drug Interactions Puzzle in Transplant Patients

Many of the immunosuppressive medications used for solid-organ transplants have known interactions with nutrition ...

SEPTEMBER 10, 2024

Study Looks at Infection Risk in Older IBD Patients on Immunosuppressive Therapies

Older adults represent a growing segment of patients with IBD, and several unique factors should be considered when ...

AUGUST 30, 2024

Benefits of Shingles Vaccine Outweigh Risks for the Immunocompromised

The benefits of vaccination with recombinant zoster vaccine outweigh safety concerns in immunocompromised ...

APRIL 17, 2024

Expert Panel Discusses the Latest Strategies For the Management of Diverticulitis

Management strategies for patients with diverticulitis have become increasingly individualized over the past five ...

MARCH 27, 2024

Review Points to Safety of FMT for CDI in Immunocompromised Patients

A study of immunocompromised patients who underwent fecal microbiota transplantation for Clostridioides difficile ...

JANUARY 19, 2022

The Scope: Talking Vaccines With Freddy Caldera, DO

After decades of calm, measles cases are on the rise, with 764 this year as of May 3, according to the CDC. But ...

MAY 20, 2019